ReviewAdvances in experimental medicine and biology2025
Guidelines for the Naming of Circular RNAs.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circular RNAs: Unlocking new avenues in cardiometabolic disease management.The Journal of physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) have emerged as pivotal regulators in the posttranscriptional regulatory landscape, exhibiting unique properties such as increased stability and a range of biological functions due to their covalently closed-loop structure. Despite advancements in circRNA research, the field meets a significant challenge in the absence of a standardized nomenclature system, leading to confusion and hindering effective scientific communication. This chapter outlines the historical development, current state, and the necessity for a unified naming system in circRNA research. We highlight the role of databases in shaping circRNA nomenclature and discuss the implications of nomenclature ambiguity, especially with the identification of multiple circRNAs from single gene loci. We propose a systematic approach to naming circRNAs that incorporates the "circ" prefix, references to GENCODE/Ensembl transcripts, and annotations for unique structural features such as retained introns or alternative splicing. The adoption of such a nomenclature system is essential for enhancing clarity, ensuring reproducibility, and advancing our understanding of circRNA investigation.
Indexed as
Identifiers
40886267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.